Veritas In Silico Inc. (JP:130A) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Veritas In Silico Inc. is focused on expanding its platform business for mRNA-targeted drug discovery through strategic contracts and in-house pipeline creation. The company aims to enhance shareholder value by transitioning into a specialty pharmaceutical company with a balanced approach of revenue generation and investment.
For further insights into JP:130A stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Deutsche Bank Pounds the Table on Broadcom Stock
- ‘Get in for 2025 Gains,’ Says Cowen on Amazon Stock
- Top Analyst Sets the Stage for Nike Stock Ahead of Earnings
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
